Transformed Follicular Lymphoma
6 clinical trials · Condition
◉ Watch Transformed Follicular Lymphoma
| Record | Firm | Date |
|---|---|---|
| Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T (NCT04488354) | Calibr, a division of Scripps Research | 2021-01-21 |
| CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies (NCT04450069) | Calibr, a division of Scripps Research | 2020-08-14 |
| Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma (NCT04833504) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-09-22 |
| Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL (NCT01897571) | Epizyme, Inc. | 2013-06-13 |
| MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine (NCT01397825) | Millennium Pharmaceuticals, Inc. | 2011-08-09 |
Track Transformed Follicular Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.